111 Total Assets 2018-2024 | YI
111 Annual Total Assets (Millions of US $) |
|
---|---|
2024 | $382 |
2023 | $435 |
2022 | $504 |
2021 | $494 |
2020 | $464 |
2019 | $231 |
2018 | $225 |
2017 | $115 |
111 Quarterly Total Assets (Millions of US $) |
|
---|---|
2024-12-31 | $382 |
2024-09-30 | $432 |
2024-06-30 | $384 |
2024-03-31 | $405 |
2023-12-31 | $435 |
2023-09-30 | $461 |
2023-06-30 | $421 |
2023-03-31 | $472 |
2022-12-31 | $504 |
2022-09-30 | $429 |
2022-06-30 | $463 |
2022-03-31 | $475 |
2021-12-31 | $494 |
2021-09-30 | $486 |
2021-06-30 | $511 |
2021-03-31 | $470 |
2020-12-31 | $464 |
2020-09-30 | $401 |
2020-06-30 | $267 |
2020-03-31 | $233 |
2019-12-31 | $231 |
2019-09-30 | $234 |
2019-06-30 | $253 |
2019-03-31 | $239 |
2018-09-30 | $247 |
2017-12-31 | $115 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.069B | $1.973B |
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $37.877B | 52.32 |
Hims & Hers Health (HIMS) | United States | $10.991B | 115.05 |
Tempus AI (TEM) | United States | $8.988B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.774B | 74.60 |
IRhythm Technologies (IRTC) | United States | $4.316B | 0.00 |
Privia Health (PRVA) | United States | $2.756B | 206.54 |
Enovis (ENOV) | United States | $1.947B | 12.05 |
Schrodinger (SDGR) | United States | $1.721B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.712B | 0.00 |
Phreesia (PHR) | United States | $1.426B | 0.00 |
Omnicell (OMCL) | United States | $1.202B | 21.21 |
Azenta (AZTA) | United States | $1.162B | 54.08 |
10x Genomics (TXG) | United States | $0.991B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.573B | 0.00 |
Talkspace (TALK) | United States | $0.530B | 157.25 |
Butterfly Network (BFLY) | United States | $0.527B | 0.00 |
Veradigm (MDRX) | United States | $0.486B | 0.00 |
Standard BioTools (LAB) | United States | $0.403B | 0.00 |
TruBridge (TBRG) | United States | $0.381B | 0.00 |
Claritev (CTEV) | United States | $0.329B | 0.00 |
Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.218B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
Pulmonx (LUNG) | United States | $0.138B | 0.00 |
American Well (AMWL) | United States | $0.106B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.095B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
CareCloud (CCLD) | United States | $0.091B | 3.45 |
MDxHealth SA (MDXH) | Belgium | $0.080B | 0.00 |
P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
HeartBeam (BEAT) | United States | $0.062B | 0.00 |
Outset Medical (OM) | United States | $0.041B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
Zhongchao (ZCMD) | China | $0.033B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
Movano (MOVE) | United States | $0.006B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |